Psoriasis With Leg Involvement, a New Difficult-to-Treat Area: A Cohort Study of Patients Treated With Risankizumab. (2024). Dermatology Practical & Conceptual, 14(3), e2024171. https://doi.org/10.5826/dpc.1403a171